Series C - Abbisko Therapeutics - Mar 25, 2020 Funding Round Profile - Cointime

Bitcoin $79,598.69 +4.08%
Ethereum $3,201.57 +5.17%
BNB $634.58 +1.31%
Optimism $1.65 +0.76%
Arbitrum $0.64 +4.78%
Solana $204.89 +1.17%
Polygon $0.41 +5.16%
Cosmos $5.23 +9.68%
Avalanche $31.86 +7.66%

Bitcoin $79,598.69 +4.08%
Ethereum $3,201.57 +5.17%
BNB $634.58 +1.31%
Optimism $1.65 +0.76%
Arbitrum $0.64 +4.78%
Solana $204.89 +1.17%
Polygon $0.41 +5.16%
Cosmos $5.23 +9.68%
Avalanche $31.86 +7.66%

Abbisko Therapeutics

company

Funding Round

Series C

Money Raised

$ 70M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 7, 2017	Series A	$ 28M	Lilly Asia Ventures	Detail
Mar 21, 2019	Series B	$ 42M	Lilly Asia Ventures	Detail